Rezaei Satar, Bazyar Mohammad, Ahmadi Sina, Khodamoradi Abdolvahed
Research Center for Environmental Determinants of Health, Health Institute Kermanshah University of Medical Sciences Kermanshah Iran.
Health Management and Economics Department, Faculty of Health Ilam University of Medical Sciences Ilam Iran.
Health Sci Rep. 2024 Oct 29;7(11):e70161. doi: 10.1002/hsr2.70161. eCollection 2024 Nov.
The COVID-19 pandemic has significantly impacted the healthcare sector, influencing patients, providers, and the overall system. This study evaluates how the pandemic affected antibiotic prescriptions among 44 million Iranians insured by the Social Security Organization (SSO).
In this quasi-experimental study, we utilized monthly aggregated data on antibiotic prescriptions per 1000 individuals insured by the SSO. We employed a single-group interrupted time series analysis (ITSA) over a period of 72 months, from March 20, 2016 to February 19, 2020 for the pre-pandemic phase, and from February 20, 2020 to March 20, 2022, for the during-pandemic period. Additionally, we conducted a multiple-group ITSA to assess the differential impact of the pandemic on antibiotic consumption between the direct (SSO-owned medical centers) and indirect (other private or public centers contracted by the SSO) sectors.
The study revealed a 30% reduction in the monthly average antibiotic consumption rate when comparing the during-pandemic period to pre-pandemic usage across the total sector. The results from the single-group ITSA indicated that the mean antibiotic consumption per 1000 individuals at baseline was 1664. Following the onset of the pandemic, there was a significant reduction in antibiotic prescriptions, dropping to 484 per 1000 individuals ( ≤ 0.001) in the first month. However, during the pandemic period, antibiotic prescriptions exhibited insignificant monthly increases, averaging 10.7 per 1000 insured individuals. The multiple-group ITSA revealed that both sectors experienced a decline in antibiotic prescriptions after the outbreak of COVID-19. Notably, the indirect sector demonstrated a greater reduction, with a decrease of 187 prescriptions per 1000 insured individuals in the first month following the pandemic's onset.
Our study found a significant reduction in antibiotic consumption. Further research is needed to compare antibiotic use between hospitals and outpatient centers, as well as among COVID-19 and non-COVID-19 patients.
新冠疫情对医疗保健行业产生了重大影响,涉及患者、医疗服务提供者及整个系统。本研究评估了疫情对社会保障组织(SSO)承保的4400万伊朗人抗生素处方的影响。
在这项准实验研究中,我们使用了SSO承保的每1000人每月抗生素处方的汇总数据。我们采用单组中断时间序列分析(ITSA),在72个月的时间内进行分析,2016年3月20日至2020年2月19日为疫情前阶段,2020年2月20日至2022年3月20日为疫情期间。此外,我们进行了多组ITSA,以评估疫情对直接(SSO所属医疗中心)和间接(SSO签约的其他私立或公立中心)部门抗生素消费的不同影响。
研究显示,与疫情前相比,整个部门在疫情期间每月平均抗生素消费率下降了30%。单组ITSA的结果表明,基线时每1000人的平均抗生素消费量为1664。疫情爆发后,抗生素处方显著减少,第一个月降至每1000人484(≤0.001)。然而,在疫情期间,抗生素处方每月增加不显著,平均每1000名参保人员增加10.7。多组ITSA显示,新冠疫情爆发后,两个部门的抗生素处方均有所下降。值得注意的是,间接部门的降幅更大,在疫情爆发后的第一个月,每1000名参保人员的处方减少了187。
我们的研究发现抗生素消费量显著下降。需要进一步研究以比较医院和门诊中心之间以及新冠患者和非新冠患者之间的抗生素使用情况。